{"id":89564,"date":"2024-06-19T12:31:49","date_gmt":"2024-06-19T15:31:49","guid":{"rendered":"https:\/\/murray.adv.br\/?p=89564"},"modified":"2024-06-19T12:31:51","modified_gmt":"2024-06-19T15:31:51","slug":"cimed-in-final-talks-to-acquire-jequiti","status":"publish","type":"post","link":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/","title":{"rendered":"Cimed in final talks to acquire Jequiti"},"content":{"rendered":"\n<h6 class=\"wp-block-heading has-text-align-center\"><em><strong>Acquisition of Grupo Silvio Santos\u2019s brand to open new business vertical for Marques family\u2019s pharmaceutical company<\/strong><\/em><\/h6>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>06\/19\/2024 <\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter is-resized\"><img decoding=\"async\" src=\"https:\/\/s2-valorinternational.glbimg.com\/x5tgLkrq7t6rswlGYgDwpLpz4rw=\/0x0:2200x1650\/984x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_37554604729d4b2f9f3eb9ad8a691345\/internal_photos\/bs\/2024\/C\/i\/6IW7BeSpGa5nOalVmqvg\/dji-0195.jpg\" alt=\"Cimed has accelerated acquisitions towards the goal of reaching R$5 billion in sales \u2014 Foto: Divulga\u00e7\u00e3o\" style=\"width:628px;height:auto\" \/><\/figure>\n<\/div>\n\n\n<p class=\"has-text-align-center\"><strong><em>Cimed has accelerated acquisitions towards the goal of reaching R$5 billion in sales \u2014 Foto: Divulga\u00e7\u00e3o<\/em><\/strong><\/p>\n\n\n\n<p>The final touches are being put on the deal between Grupo Silvio Santos and Cimed for the sale of Jequiti to the pharmaceutical company owned by Jo\u00e3o Adibe Marques. Initially discussed as a majority stake purchase, the negotiations have evolved in recent weeks toward a complete acquisition. The remaining adjustments now revolve around the price.<\/p>\n\n\n\n<p>\u201cThere was already a consensus on the price for the majority stake, and Cimed has detailed plans for the operation. When discussions moved to shareholder agreement details, it became clear to both parties that a complete acquisition was more appropriate,\u201d said a source.<\/p>\n\n\n\n<p>Jequiti is being valued at around R$450 million, equivalent to its revenue, according to Pipeline, Valor\u2019s business website. While Cimed is seeking a discount and Grupo Silvio Santos is aiming for a premium, the final check is expected to be in this range, sources say. The agreement also includes facilitated brand exposure during prime time on TV channel SBT, similar to the current arrangement. The brand has been boosted on TV over the past decade by the show \u201cRoda a Roda Jequiti,\u201d attracting customers and consultants seeking prizes.<\/p>\n\n\n\n<p>Mr. Marques has also reached an agreement with Governor Romeu Zema of Minas Gerais to establish a factory and distribution center for cosmetics in the southern part of the state, benefiting from tax incentives, Pipeline found.<\/p>\n\n\n\n<p>Jequiti, which had years of financial losses, has now returned to profitability. The new owner will integrate a national distribution network, bringing products from one of the main medium-class brands to small neighborhood pharmacies in rural towns.<\/p>\n\n\n\n<p>On the other hand, Jequiti brings Cimed a robust outsourced sales force: the brand\u2019s consultants, a door-to-door strategy Mr. Marques had on his radar for vitamins, baby products, and hygiene and beauty items. Jequiti boasts a team of over 200,000 consultants, and Mr. Marques plans to launch this direct sales initiative in the second half of this year, using pharmacy stock in what he describes as \u201cthe salesperson outside the store.\u201d<\/p>\n\n\n\n<p>\u201cThis is transformational for Cimed. The company was already growing with consumer products in addition to generics, but Jequiti opens an entire new vertical,\u201d said an executive familiar with the matter.<\/p>\n\n\n\n<p>Experience with Carmed lip balms has shown that Mr. Marques knows how to sell consumer items: Carmed generated R$400 million in revenue in the second half of last year through collaborations and limited editions. The goal is to reach an annual revenue of R$1 billion from this product alone.<\/p>\n\n\n\n<p>For the Jequiti transaction, Cimed is receiving legal advice from Machado Meyer, without a financial advisor. Grupo Silvio Santos is being advised by Bradesco BBI and Lefosse Advogados.<\/p>\n\n\n\n<p>Cimed benefits from low leverage, with room for M&amp;A, and low financing costs in the capital market. The leverage ratio is below 0.8 times, and the group recently completed its third debenture issuance. Distributed by XP Investimentos, it raised R$600 million with a DI rate plus 0.75% per year (less than half the spread of the previous issuance) and a five-year term.<\/p>\n\n\n\n<p>Cimed, which grossed R$3 billion last year, aims to reach R$5 billion by 2025, bringing it closer to a potential IPO. The company has been courted by banks.<\/p>\n\n\n\n<p>Both Cimed and Jequiti did not respond to requests for comments.<\/p>\n\n\n\n<p><em>The original story in Portuguese was first published on Valor\u2019s business news website, Pipeline.<\/em><\/p>\n\n\n\n<p>*Por Maria Lu\u00edza Filgueiras\u00a0\u2014 S\u00e3o Paulo<\/p>\n\n\n\n<p>Source: Valor International<\/p>\n\n\n\n<figure class=\"wp-block-embed\"><div class=\"wp-block-embed__wrapper\">\nhttps:\/\/valorinternational.globo.com\/\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Acquisition of Grupo Silvio Santos\u2019s brand to open new business vertical for Marques family\u2019s pharmaceutical company 06\/19\/2024 Cimed has accelerated acquisitions towards the goal of reaching R$5 billion in sales \u2014 Foto: Divulga\u00e7\u00e3o The final touches are being put on the deal between Grupo Silvio Santos and Cimed for the sale of Jequiti to the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8106],"tags":[25177,25178],"class_list":["post-89564","post","type-post","status-publish","format-standard","hentry","category-murray-news","tag-cimed-in-final-talks-to-acquire-jequiti","tag-marques-familys-pharmaceutical-company"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cimed in final talks to acquire Jequiti - Murray Advogados<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cimed in final talks to acquire Jequiti - Murray Advogados\" \/>\n<meta property=\"og:description\" content=\"Acquisition of Grupo Silvio Santos\u2019s brand to open new business vertical for Marques family\u2019s pharmaceutical company 06\/19\/2024 Cimed has accelerated acquisitions towards the goal of reaching R$5 billion in sales \u2014 Foto: Divulga\u00e7\u00e3o The final touches are being put on the deal between Grupo Silvio Santos and Cimed for the sale of Jequiti to the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/\" \/>\n<meta property=\"og:site_name\" content=\"Murray Advogados\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-19T15:31:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-19T15:31:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s2-valorinternational.glbimg.com\/x5tgLkrq7t6rswlGYgDwpLpz4rw=\/0x0:2200x1650\/984x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_37554604729d4b2f9f3eb9ad8a691345\/internal_photos\/bs\/2024\/C\/i\/6IW7BeSpGa5nOalVmqvg\/dji-0195.jpg\" \/>\n<meta name=\"author\" content=\"Gelcy Bueno\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gelcy Bueno\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/\"},\"author\":{\"name\":\"Gelcy Bueno\",\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e\"},\"headline\":\"Cimed in final talks to acquire Jequiti\",\"datePublished\":\"2024-06-19T15:31:49+00:00\",\"dateModified\":\"2024-06-19T15:31:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/\"},\"wordCount\":611,\"image\":{\"@id\":\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/s2-valorinternational.glbimg.com\/x5tgLkrq7t6rswlGYgDwpLpz4rw=\/0x0:2200x1650\/984x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_37554604729d4b2f9f3eb9ad8a691345\/internal_photos\/bs\/2024\/C\/i\/6IW7BeSpGa5nOalVmqvg\/dji-0195.jpg\",\"keywords\":[\"Cimed in final talks to acquire Jequiti\",\"Marques family\u2019s pharmaceutical company\"],\"articleSection\":[\"Murray News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/\",\"url\":\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/\",\"name\":\"Cimed in final talks to acquire Jequiti - Murray Advogados\",\"isPartOf\":{\"@id\":\"https:\/\/murray.adv.br\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/s2-valorinternational.glbimg.com\/x5tgLkrq7t6rswlGYgDwpLpz4rw=\/0x0:2200x1650\/984x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_37554604729d4b2f9f3eb9ad8a691345\/internal_photos\/bs\/2024\/C\/i\/6IW7BeSpGa5nOalVmqvg\/dji-0195.jpg\",\"datePublished\":\"2024-06-19T15:31:49+00:00\",\"dateModified\":\"2024-06-19T15:31:51+00:00\",\"author\":{\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e\"},\"breadcrumb\":{\"@id\":\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#primaryimage\",\"url\":\"https:\/\/s2-valorinternational.glbimg.com\/x5tgLkrq7t6rswlGYgDwpLpz4rw=\/0x0:2200x1650\/984x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_37554604729d4b2f9f3eb9ad8a691345\/internal_photos\/bs\/2024\/C\/i\/6IW7BeSpGa5nOalVmqvg\/dji-0195.jpg\",\"contentUrl\":\"https:\/\/s2-valorinternational.glbimg.com\/x5tgLkrq7t6rswlGYgDwpLpz4rw=\/0x0:2200x1650\/984x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_37554604729d4b2f9f3eb9ad8a691345\/internal_photos\/bs\/2024\/C\/i\/6IW7BeSpGa5nOalVmqvg\/dji-0195.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/murray.adv.br\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cimed in final talks to acquire Jequiti\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/murray.adv.br\/en\/#website\",\"url\":\"https:\/\/murray.adv.br\/en\/\",\"name\":\"Murray Advogados\",\"description\":\"PLG International Lawyers\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/murray.adv.br\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e\",\"name\":\"Gelcy Bueno\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g\",\"caption\":\"Gelcy Bueno\"},\"url\":\"https:\/\/murray.adv.br\/en\/author\/news\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cimed in final talks to acquire Jequiti - Murray Advogados","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/","og_locale":"en_US","og_type":"article","og_title":"Cimed in final talks to acquire Jequiti - Murray Advogados","og_description":"Acquisition of Grupo Silvio Santos\u2019s brand to open new business vertical for Marques family\u2019s pharmaceutical company 06\/19\/2024 Cimed has accelerated acquisitions towards the goal of reaching R$5 billion in sales \u2014 Foto: Divulga\u00e7\u00e3o The final touches are being put on the deal between Grupo Silvio Santos and Cimed for the sale of Jequiti to the [&hellip;]","og_url":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/","og_site_name":"Murray Advogados","article_published_time":"2024-06-19T15:31:49+00:00","article_modified_time":"2024-06-19T15:31:51+00:00","og_image":[{"url":"https:\/\/s2-valorinternational.glbimg.com\/x5tgLkrq7t6rswlGYgDwpLpz4rw=\/0x0:2200x1650\/984x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_37554604729d4b2f9f3eb9ad8a691345\/internal_photos\/bs\/2024\/C\/i\/6IW7BeSpGa5nOalVmqvg\/dji-0195.jpg","type":"","width":"","height":""}],"author":"Gelcy Bueno","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Gelcy Bueno","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#article","isPartOf":{"@id":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/"},"author":{"name":"Gelcy Bueno","@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e"},"headline":"Cimed in final talks to acquire Jequiti","datePublished":"2024-06-19T15:31:49+00:00","dateModified":"2024-06-19T15:31:51+00:00","mainEntityOfPage":{"@id":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/"},"wordCount":611,"image":{"@id":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#primaryimage"},"thumbnailUrl":"https:\/\/s2-valorinternational.glbimg.com\/x5tgLkrq7t6rswlGYgDwpLpz4rw=\/0x0:2200x1650\/984x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_37554604729d4b2f9f3eb9ad8a691345\/internal_photos\/bs\/2024\/C\/i\/6IW7BeSpGa5nOalVmqvg\/dji-0195.jpg","keywords":["Cimed in final talks to acquire Jequiti","Marques family\u2019s pharmaceutical company"],"articleSection":["Murray News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/","url":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/","name":"Cimed in final talks to acquire Jequiti - Murray Advogados","isPartOf":{"@id":"https:\/\/murray.adv.br\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#primaryimage"},"image":{"@id":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#primaryimage"},"thumbnailUrl":"https:\/\/s2-valorinternational.glbimg.com\/x5tgLkrq7t6rswlGYgDwpLpz4rw=\/0x0:2200x1650\/984x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_37554604729d4b2f9f3eb9ad8a691345\/internal_photos\/bs\/2024\/C\/i\/6IW7BeSpGa5nOalVmqvg\/dji-0195.jpg","datePublished":"2024-06-19T15:31:49+00:00","dateModified":"2024-06-19T15:31:51+00:00","author":{"@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e"},"breadcrumb":{"@id":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#primaryimage","url":"https:\/\/s2-valorinternational.glbimg.com\/x5tgLkrq7t6rswlGYgDwpLpz4rw=\/0x0:2200x1650\/984x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_37554604729d4b2f9f3eb9ad8a691345\/internal_photos\/bs\/2024\/C\/i\/6IW7BeSpGa5nOalVmqvg\/dji-0195.jpg","contentUrl":"https:\/\/s2-valorinternational.glbimg.com\/x5tgLkrq7t6rswlGYgDwpLpz4rw=\/0x0:2200x1650\/984x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_37554604729d4b2f9f3eb9ad8a691345\/internal_photos\/bs\/2024\/C\/i\/6IW7BeSpGa5nOalVmqvg\/dji-0195.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/murray.adv.br\/en\/cimed-in-final-talks-to-acquire-jequiti\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/murray.adv.br\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Cimed in final talks to acquire Jequiti"}]},{"@type":"WebSite","@id":"https:\/\/murray.adv.br\/en\/#website","url":"https:\/\/murray.adv.br\/en\/","name":"Murray Advogados","description":"PLG International Lawyers","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/murray.adv.br\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e","name":"Gelcy Bueno","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g","caption":"Gelcy Bueno"},"url":"https:\/\/murray.adv.br\/en\/author\/news\/"}]}},"_links":{"self":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts\/89564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/comments?post=89564"}],"version-history":[{"count":1,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts\/89564\/revisions"}],"predecessor-version":[{"id":89565,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts\/89564\/revisions\/89565"}],"wp:attachment":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/media?parent=89564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/categories?post=89564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/tags?post=89564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}